Molbio Diagnostics is a POC (point-of-care) diagnostics company offering rapid, decentralized molecular testing solutions for infectious and non-communicable diseases. Its flagship platform, Truenat, ...

Researchers have developed a device -- a breath test that uses a biosensor -- as a tool for use in doctors' offices and crowded public locations to quickly diagnose people infected with the virus that ...

As if you needed another health concern to worry about — beyond the “explosive diarrhea” stomach parasite causing a surge of sicknesses around the United States — the COVID-19 virus has made a ...

LymeAlert will hit the market in August. The latest tool against the tick-borne illness could become a medicine cabinet ...

New research has revealed how light can be used to destroy infectious coronavirus particles that contaminate surfaces. Scientists are interested in how environments, such as surgeries, can be ...

Molbio Diagnostics IPO opens today at ₹768-807; brokerages recommend subscribing for long-term growth potential in molecular ...

The BEATOZ Foundation announced on August 4 that it has signed a formal agreement with HashKey Cloud to strengthen the ...

In a sea of lookalike bike helmets, POC has always stood out from the crowd by matching first-class performance with distinctive design. That continues with the new Amidal – the Swedish firm’s latest ...

The point-of-care molecular diagnostics Market is experiencing robust growth, driven by the increasing demand for rapid, accurate, and decentralized diagnostic testing across infectious diseases, ...

The company also submitted a request for a CLIA waiver for the test, which would permit its use in decentralized testing locations.